DK1112060T3 - Doseringsform anvendende flydende formulering - Google Patents

Doseringsform anvendende flydende formulering

Info

Publication number
DK1112060T3
DK1112060T3 DK99944089T DK99944089T DK1112060T3 DK 1112060 T3 DK1112060 T3 DK 1112060T3 DK 99944089 T DK99944089 T DK 99944089T DK 99944089 T DK99944089 T DK 99944089T DK 1112060 T3 DK1112060 T3 DK 1112060T3
Authority
DK
Denmark
Prior art keywords
dosage form
liquid formulation
emulsifies
self
disclosed
Prior art date
Application number
DK99944089T
Other languages
Danish (da)
English (en)
Inventor
Liang C Dong
Patrick S-L Wong
Steven D Espinal
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK1112060T3 publication Critical patent/DK1112060T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99944089T 1998-09-09 1999-09-03 Doseringsform anvendende flydende formulering DK1112060T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9961998P 1998-09-09 1998-09-09

Publications (1)

Publication Number Publication Date
DK1112060T3 true DK1112060T3 (da) 2006-04-18

Family

ID=22275865

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99944089T DK1112060T3 (da) 1998-09-09 1999-09-03 Doseringsform anvendende flydende formulering

Country Status (19)

Country Link
EP (1) EP1112060B1 (zh)
JP (1) JP2002524407A (zh)
KR (1) KR100620292B1 (zh)
CN (1) CN1227003C (zh)
AT (1) ATE311858T1 (zh)
AU (1) AU751086B2 (zh)
CA (1) CA2341297C (zh)
CY (1) CY1105465T1 (zh)
DE (1) DE69928815T2 (zh)
DK (1) DK1112060T3 (zh)
ES (1) ES2251840T3 (zh)
HK (1) HK1038508B (zh)
HU (1) HU226669B1 (zh)
IL (2) IL141914A0 (zh)
NO (1) NO20011217L (zh)
NZ (1) NZ510020A (zh)
RU (1) RU2227021C2 (zh)
WO (1) WO2000013663A1 (zh)
ZA (1) ZA200101994B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL164163A0 (en) * 2002-04-09 2005-12-18 Pharmacia Corp Process for preparing a finely self-emulsifiable pharmaceutical composition
US20040091538A1 (en) * 2002-10-31 2004-05-13 Crystal Pollock-Dove Dosage form providing ascending release of liquid formulation
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2007083323A2 (en) * 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
DE602007009377D1 (de) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
US7682356B2 (en) 2006-08-09 2010-03-23 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies for use therein
JP5351884B2 (ja) 2007-04-23 2013-11-27 インターシア セラピューティクス，インコーポレイティド インスリン分泌促進性ペプチドの懸濁製剤及び使用
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
HUE035862T2 (en) 2009-09-28 2018-05-28 Intarcia Therapeutics Inc Rapid development and / or completion of substantially steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CN103933017A (zh) * 2014-03-26 2014-07-23 邵娜 一种黄体酮缓释胶囊
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
WO2017200943A1 (en) 2016-05-16 2017-11-23 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
CN115490316B (zh) * 2022-01-24 2023-09-12 成都理工大学 一种可再利用的地下水营养物质缓释胶囊体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580961A5 (en) * 1972-01-13 1976-10-29 Alza Corp Dispenser - functioning by osmotic pressure using active agents in solid or semi solid form
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
AU591171B2 (en) * 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
AU7640294A (en) * 1993-08-31 1995-03-22 Alza Corporation Dispenser containing hydrophobic agent
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
ES2183841T3 (es) * 1994-06-13 2003-04-01 Alza Corp Formas de dosificacion para administrar un farmasco en una formulacion lquidid.
US5633011A (en) * 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations

Also Published As

Publication number Publication date
NZ510020A (en) 2003-06-30
WO2000013663A1 (en) 2000-03-16
ATE311858T1 (de) 2005-12-15
JP2002524407A (ja) 2002-08-06
CA2341297C (en) 2009-02-24
HK1038508A1 (en) 2002-03-22
IL141914A (en) 2008-06-05
DE69928815D1 (de) 2006-01-12
CN1316897A (zh) 2001-10-10
RU2227021C2 (ru) 2004-04-20
HU226669B1 (en) 2009-06-29
HUP0104034A3 (en) 2002-12-28
IL141914A0 (en) 2002-03-10
EP1112060B1 (en) 2005-12-07
CY1105465T1 (el) 2010-04-28
EP1112060A1 (en) 2001-07-04
AU5705199A (en) 2000-03-27
HUP0104034A2 (hu) 2002-04-29
KR100620292B1 (ko) 2006-09-13
DE69928815T2 (de) 2006-06-29
KR20010086394A (ko) 2001-09-10
ZA200101994B (en) 2002-03-11
ES2251840T3 (es) 2006-05-01
HK1038508B (zh) 2006-06-30
AU751086B2 (en) 2002-08-08
NO20011217L (no) 2001-05-08
NO20011217D0 (no) 2001-03-09
CA2341297A1 (en) 2000-03-16
CN1227003C (zh) 2005-11-16

Similar Documents

Publication Publication Date Title
DK1112060T3 (da) Doseringsform anvendende flydende formulering
ATE312602T1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
NO20022998D0 (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
DE60019334D1 (de) Antivirale arznei
DE69525148T2 (de) Pharmazeutische formulierung
NO20022970D0 (no) Hydrogel-drevet medikamentdoseringsform
EE04002B1 (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja antatsiidainet või alginaati
EE04003B1 (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja NSAID
DK1208864T4 (da) Forbedringer til lægemiddelafgivelsesindretninger
DE69928085D1 (de) Dosierungsform mit verlängerter wirkstoffabgabe
NO20030627L (no) Hydrogel-drevet medikament doseringsform
ID24654A (id) Formulasi farmasi omeprazola
ID27504A (id) Formulasi oral baru
DE69928777D1 (de) Dosierspender
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
PT768867E (pt) Forma de dosagem para a administracao de droga em formulacao liquida
NO20020086D0 (no) Smaksmaskerte farmasöytiske flytende formuleringer
ATE429224T1 (de) Arzneizubereitungen enthaltend mindestens einen hiv preoteaseinhibitor
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
EE05415B1 (et) Ravimi manustamise vahend, eriti androgeenide manustamiseks
ID30032A (id) Formulasi farmasi
FI973230A (fi) Uusi farmaseuttinen formulaatio
DE19681529D2 (de) Pharmazeutische Darreichungsform
PT1014951E (pt) Composicao de revestimento farmaceutica e metodo para a sua utilizacao